Hybrid psychological well being and dependancy care startup Eleanor Well being introduced in $50 million in a Sequence C funding spherical led by Basic Catalyst.
Different buyers collaborating within the elevate embrace Warburg Pincus, City Corridor Ventures, Northpond Ventures and Rethink Influence.
The most recent spherical comes lower than a 12 months after a $20 million Sequence B. In line with Crunchbase, Eleanor has scooped up a complete of $82 million in enterprise capital.
WHAT IT DOES
The startup presents in-person and digital psychiatry, remedy, restoration teaching and medication-assisted therapy for substance use problems.
It at the moment operates in Louisiana, Massachusetts, New Jersey, North Carolina, Ohio and Washington. With the most recent inflow of capital, Eleanor plans to develop to new markets, together with Texas.
The startup additionally plans so as to add extra partnerships with payers the place they each tackle threat and proceed constructing out its care supply and analytics platform.
“Psychological well being and dependancy are a few of our greatest well being crises, however the issue is not only about entry to care,” Corbin Petro, CEO and cofounder of Eleanor Well being, stated in an announcement.
“Just one in 10 folks with SUD and fewer than half of individuals with a psychological well being situation obtain therapy, largely because of stigma, high quality of care and price. Our population- and value-based fashions are designed for the 9 out of 10 folks which will by no means obtain care due to these obstacles. We’re so completely satisfied to associate with buyers like Basic Catalyst to additional our mission of serving to folks affected by dependancy and different psychological well being circumstances reside superb lives.”
Psychological and behavioral well being is a well-liked scientific space for digital well being buyers. Drug overdose deaths have typically elevated over the previous twenty years, with a big spike in the course of the COVID-19 pandemic.
Nonetheless, there are a selection of startups that goal to enhance entry to therapy. Pear Therapeutics, which makes prescription digital therapeutics reSET and reSET-O for substance and opioid use problems, introduced earlier this week it could start providing its instruments by way of choose telehealth suppliers.
Give up Genius, an addiction-treatment platform centered on alcohol, tobacco and opioids, moved into the payer house this week with a partnership with Evry Well being to incorporate its digital companies for Evry’s members.
Psychological well being startup Cerebral additionally just lately launched an opioid use dysfunction program that features digital counseling and entry to Suboxone.